ANSM — authorised 7 August 2019
- Status: approved
ANSM authorised Talzenna on 7 August 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. ANSM authorised it on 7 August 2019.
Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.